ArticleFrontiers in medicine2025
AHP-MOORA framework for longitudinal evaluation of Pharm.D program learning outcomes: a tool for Saudi pharmacy programs accreditation and curriculum enhancement.
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Effects of NCAAA Accreditation on Health Sciences Educational Programs: Faculty Experiences at KSAU-HS.Journal of healthcare leadership · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: As pharmacy education in Saudi Arabia progresses in accordance with Saudi Vision 2030 and international competency-based standards, the necessity for systematic evaluation of Program Learning Outcomes (PLOs) has become essential. This study aimed to establish a scalable framework for evaluating PLOs' achievement under the National Commission for Academic Accreditation and Assessment (NCAAA) criteria. Methods: A mixed-methods methodology was utilized in a public pharmacy institution in Saudi Arabia. Eight PLOs derived from the Pharm.D program framework were assessed utilizing stakeholder feedback and national quality standards. The analytical hierarchy process (AHP) was employed to prioritize outcomes, while the Multi-Objective Optimization by Ratio Analysis (MOORA) technique was utilized to evaluate performance over five graduating cohorts (2018-2022). Data sources comprised alumni employment data, postgraduate enrollment, and professional practice positions. A program based on Microsoft Access was created for data administration and visualization. Results: PLO2 (clinical application) and PLO5 (ethics and professionalism) earned the greatest AHP weights, measuring 0.28 and 0.19, respectively. Composite MOORA scores exhibited optimal performance in 2020 (0.883) and declined to 0.792 in 2022. The decline in 2022 may be attributed to reduced clinical training opportunities and delayed workforce absorption following COVID-19-related disruptions, as documented in comparable educational settings. The technology facilitated long-term trend analysis and cohort-specific reporting. Conclusion: The holistic monitoring tool established a durable framework for evaluating PLOs attainment by national accreditation standards. It facilitated evidence-based enhancements to the curriculum and enhanced institutional quality assurance. The widespread application of this strategy in pharmacy colleges, including digital integration and external benchmarking, can increase accreditation preparedness and facilitate ongoing educational enhancement.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.